Literature DB >> 19242521

Induction of SREBP-1c mRNA by differentiation and LXR ligand in human keratinocytes.

Ai Yokoyama1, Makoto Makishima, Mihwa Choi, Yoshitake Cho, Shigeru Nishida, Yuichi Hashimoto, Tadashi Terui.   

Abstract

The epidermis is an active site of lipid metabolism, and the synthesis of fatty acids and cholesterol is required for cutaneous homeostasis. Liver X receptor-alpha (LXRalpha) and LXRbeta are nuclear receptors that are activated by oxysterols and regulate cholesterol and fatty acid metabolism. LXRs, predominantly LXRbeta, have been shown to be involved in keratinocyte differentiation and epidermal permeability barrier function. Although LXR regulates hepatic lipogenesis by inducing sterol-regulatory element-binding protein-1c (SREBP-1c), SREBP-1c induction by LXR in the epidermis has not been studied. In this study, we report that SREBP-1c mRNA increased during differentiation of human keratinocyte HaCaT cells and that LXR agonist effectively induced expression of LXR target genes, including SREBP-1c and ATP-binding cassette transporter A1, in differentiated HaCaT cells. Differentiation-associated and LXR-enhanced expression of SREBP-1c was also observed in malignant human keratinocyte A431 cells and primary human keratinocytes. A synthetic LXR antagonist inhibited confluency-dependent expression of SREBP-1c. Thus, SREBP-1c expression increases during keratinocyte differentiation, and LXR activation enhances its expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242521     DOI: 10.1038/jid.2009.15

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Sterol regulatory element-binding proteins are regulators of the NIS gene in thyroid cells.

Authors:  Robert Ringseis; Christine Rauer; Susanne Rothe; Denise K Gessner; Lisa-Marie Schütz; Sebastian Luci; Gaiping Wen; Klaus Eder
Journal:  Mol Endocrinol       Date:  2013-03-29

2.  Lipidomics analysis of facial lipid biomarkers in females with self-perceived skin sensitivity.

Authors:  Yuchen Ma; Le Cui; Yan Tian; Congfen He
Journal:  Health Sci Rep       Date:  2022-05-06

3.  Cutaneous glucocorticosteroidogenesis: securing local homeostasis and the skin integrity.

Authors:  Andrzej T Slominski; Pulak R Manna; Robert C Tuckey
Journal:  Exp Dermatol       Date:  2014-06       Impact factor: 3.960

4.  Possible Involvement of F1F0-ATP synthase and Intracellular ATP in Keratinocyte Differentiation in normal skin and skin lesions.

Authors:  Xie Xiaoyun; Han Chaofei; Zeng Weiqi; Chen Chen; Lu Lixia; Liu Queping; Peng Cong; Zhao Shuang; Su Juan; Chen Xiang
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

5.  The trisaccharide raffinose modulates epidermal differentiation through activation of liver X receptor.

Authors:  Tae-Young Na; Gyeong-Hwan Kim; Hyeon-Jeong Oh; Min-Ho Lee; Yong-Hyun Han; Ki Taek Kim; Ji-Su Kim; Dae-Duk Kim; Mi-Ock Lee
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

6.  Keratin 17 Is Required for Lipid Metabolism in Keratinocytes and Benefits Epidermal Permeability Barrier Homeostasis.

Authors:  Bingyu Pang; Zhenlai Zhu; Chunying Xiao; Yixin Luo; Hui Fang; Yaxing Bai; Zhongbin Sun; Jingyi Ma; Erle Dang; Gang Wang
Journal:  Front Cell Dev Biol       Date:  2022-01-12

7.  Fatostatin ameliorates inflammation without affecting cell viability.

Authors:  Shuhe Ma; Kosaku Murakami; Kazune Tanaka; Motomu Hashimoto; Masao Tanaka; Koji Kitagori; Shuji Akizuki; Ran Nakashima; Hajime Yoshifuji; Koichiro Ohmura; Akio Morinobu; Tsuneyo Mimori
Journal:  FEBS Open Bio       Date:  2022-02-01       Impact factor: 2.693

Review 8.  Role of mTOR Signaling Cascade in Epidermal Morphogenesis and Skin Barrier Formation.

Authors:  Juan Wang; Sabine A Eming; Xiaolei Ding
Journal:  Biology (Basel)       Date:  2022-06-19

9.  Elucidating mechanistic insights into drug action for atopic dermatitis: a systems biology approach.

Authors:  Indhupriya Subramanian; Vivek K Singh; Abhay Jere
Journal:  BMC Dermatol       Date:  2018-02-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.